DT
XENE icon

Diversified Trust’s Xenon Pharmaceuticals XENE Stock Holding History

Diversified Trust’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
+39,222
New +$2.18M 0.04% 231

Other funds holding XENE

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Diversified Trust's XENE Position: Q2 2026 in Review

Diversified Trust opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 39,222 shares worth $2.37M. The stake represents 0.04% of the portfolio and ranks #231 among its holdings.

14 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Diversified Trust held 39,222 shares of Xenon Pharmaceuticals worth $2.37M as of Q2 2026.
  • Xenon Pharmaceuticals was a new Diversified Trust position in Q2 2026.
  • Xenon Pharmaceuticals made up 0.04% of Diversified Trust's portfolio in Q2 2026, its #231 holding.
  • 14 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.